Skip to main content
Premium Trial:

Request an Annual Quote

BGI Extends Offer for Complete Genomics Again

NEW YORK (GenomeWeb News) – BGI-Shenzhen has again extended its cash tender offer for Complete Genomics, the firm said Friday.

The $118 million offer already has been extended a few times as BGI awaits approval from China's Ministry of Commerce and the State Administration of Foreign Exchange.

The offer is now set to expire at midnight EST on Feb. 6. It was previously extended to midnight on Feb. 1.

As of the close of business on Friday, approximately 30,836,847 shares representing 87 percent of Complete Genomics' outstanding stock had been validly tendered and not withdrawn.

The Scan

Looking for Omicron

NPR reports that SARS-CoV-2 testing in the US has gotten better but also that some experts say more needs to be done to better track the Omicron variant.

Holmes Alleges Abuse

The Associated Press reports that Theranos' Elizabeth Holmes has testified at her wire fraud trial that her business and romantic partner abused her.

Bit More Diverse, But More to Do

While Black and Hispanic patients are more likely to participate in cancer clinical trials than previously, they are still underrepresented, according to US News & World Report.

PNAS Papers on Yeast Gene Silencing, Zika Virus Inhibition, Immunoglobulin Hypermutation

In PNAS this week: gene silencing in Saccharomyces cerevisiae, possible neuroprotective role for SHFL in a mouse model of Zika virus infection, and more.